Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes Among Socioeconomically Disadvantaged Communities [NA]

View source ↗

Summary

A University of Wisconsin–Madison sponsored trial plans to use artificial intelligence to prevent vision loss in people with diabetes, with a focus on socioecon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Vision, Diabetes | NA | Status: NOT_YET_RECRUITING